TickrTrends PHAT fair value analysis

PHAT Initiates Coverage On Leerink Partners -- Rating Set to Market Perform

gurufocus.com · 2026-09-09

Phathom Pharmaceuticals: Analyst Coverage Initiation and Valuation Insights On October 17, 2023, Phathom Pharmaceuticals (PHAT) received a new analyst rating

Read the full story at gurufocus.com →

Is PHAT undervalued? See TickrTrends' fair value analysis →